T&R Biofab Co., Ltd. (KOSDAQ:246710)

South Korea · Delayed Price · Currency is KRW

2,065.00

-135.00 (-6.14%)

Oct 12, 2026, 3:30 PM KST

Market Cap	98.42B +114.4%
Revenue (ttm)	32.73B +120.9%
Net Income	-27.71B
EPS	-614.92
Shares Out	47.66M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	128,356
Open	2,165.00
Previous Close	2,200.00
Day's Range	2,065.00 - 2,195.00
52-Week Range	1,127.00 - 4,925.00
Beta	0.41
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 1, 2026

About T&R Biofab

T&R Biofab Co., Ltd. develops and commercializes various regenerative medical technologies. It offers 3D-printed medical devices; and bio-surgical solutions, which includes wound dressing and acellular dermal matrix, as well as biomaterials and biopharmaceuticals. The company was founded in 2013 and is based in Siheung-si, South Korea. [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2013

Employees 86

Stock Exchange KOSDAQ

Ticker Symbol 246710

Full Company Profile

Financial Performance

In 2025, T&R Biofab's revenue was 26.97 billion, an increase of 453.32% compared to the previous year's 4.87 billion. Losses were -31.95 billion, 316.1% more than in 2024.

Financial Statements